BioSpace News Archive

Spectro Scientific, one of the world’s largest suppliers of fluid analysis instrumentation and software, has been purchased by AMETEK, Inc. Spectro has annual sales of approximately $50 million and was acquired for approximately $190 million.

Infertility is a major clinical concern, affecting 15% of all reproductive-age couples. Pollution, smoking and trends toward a Western-style diet (generally characterized by processed and refined foods, high in sugar, salt, saturated fat and protein from processed and red meat) are hypothesized as potential causes of infertility

Venous thromboembolism (VTE), a term referring to blood clots in the veins, is a highly prevalent and far-reaching public health problem that can cause disability and death.

BeyondSpring Inc. (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative cancer therapies, today announced that the Japan Patent Office (JPO) has granted the Company a new patent—JP Patent No. 6,411,523—for certain methods of preventing chemotherapy-induced neutropenia (CIN) with BeyondSpring’s lead asset, Plinabulin, a marine-derived small-molecule, in combination with taxane.

-The Senior Care Pharmacy Coalition (SCPC) today said its initial review of the Centers for Medicare and Medicaid Services (CMS) proposed changes to Medicare Advantage and Part D programs to “lower drug prices and reduce out-of-pocket expenses” would, in actuality, threaten seniors’ access to essential medications, and further undermine the economic viability of long-term care (LTC) pharmacies.

Legal-Medical Partnership Will Make Case for Babies and Children to Have Their Interests Represented in the Nationwide Opioid Litigation

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for LYRICA

Earlier this week, the FDA announced new steps to modernize FDA’s 510(k) clearance pathway, used for low- to moderate-risk devices that are substantially equivalent to a device already on the market, known as a predicate device.

Bausch Health Companies Inc. announced today that it has entered into an incremental term loan facility amendment (the “Incremental Amendment”) to its credit agreement, pursuant to which Valeant Pharmaceuticals International (“VPI”), a Delaware corporation and a wholly owned indirect subsidiary of the Company, borrowed $1,500,000,000 of new term B loans.

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company, today reported that data from three abstracts—including an oral presentation—were accepted for presentation at the 60th American Society of Hematology Annual Meeting (ASH 2018)